Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

Antonella d’Arminio Monforte, Carlo Torti, Antonio Di Biagio et al.|Journal of Antimicrobial Chemotherapy|2024

Cited by 9